SlideShare a Scribd company logo
35-‫ا‬ ‫ن‬
35 - CLIMACTERIC
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
1
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
‫ول‬ ‫و‬ ‫ا‬ ‫ن‬-‫ا‬ ‫ن‬ ‫د‬ ‫و‬
MENOPAUSE AND PERI- AND
POSTMENOPAUSE
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
2
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
3
‫ر‬‫ا‬ ‫ن‬‫در‬ ‫ص‬ ‫دث‬ ‫ث‬ ‫ا‬ ‫رأة‬ ‫ا‬ ‫ة‬ # $ ‫ر‬ ‫ا‬ % ‫ا‬#
‫و‬ ‫ا‬ ‫دات‬ ‫رو‬ ‫ا‬ ‫ج‬ ‫إ‬ # ‫ص‬ % ‫ا‬ ‫ؤدي‬ ‫ا‬ + ‫وظ‬ ‫ا‬‫ك‬ ‫ذ‬ ‫/ن‬ 0.
‫ن‬ ‫دم‬ ‫ا‬ $ ‫ط‬ ‫ھو‬.
‫ا‬ ‫ن‬:
6 ‫ط‬ ‫دورة‬ ‫ر‬ ‫آ‬.
‫ث‬ ‫ط‬ ‫دون‬ ‫دة‬ ‫وا‬.
50-55.
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
4
‫ا‬ ‫د‬ ‫ا‬ ‫ت‬ ً !" ‫ا‬ ‫أ$ل‬ ‫ض‬ ‫ا‬ & '‫د‬ ! ‫د(ت‬ "،!‫و‬ ، *+" ‫و‬ !,‫ز‬
‫رة‬+ , ‫ر‬ /" ‫0ون‬ ‫$د‬‫ط‬‫ة‬ ‫ا‬.
‫دث‬ "4‫ا‬4006 ‫رى‬ 8‫ا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫0ل‬ ‫د‬ *"‫و‬ ، ‫رة‬‫ر"ق‬ ‫ا‬atresia.
‫وغ‬ ‫ا‬ ‫د‬ ,menarche:400,000
‫و(دة‬ ‫ا‬ ‫د‬ ,:1.5‫ون‬oocytes.
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
5
HORMONAL CHANGES
‫در‬‫أن‬‫;س‬ ‫ا‬ ‫ن‬ ‫دث‬‫و=ف‬ ‫>ل‬ %$/‫ا‬ + ‫وظ‬ ? +‫ض‬.
•‫إ‬ @‫ظ‬ ‫ر‬ A 6 ‫ط‬ ‫دورات‬.
•‫رة‬ ‫ز‬A ‫وث‬ ‫ط‬.
•‫م‬ ‫ر‬ ‫ا‬ ‫ط‬ C D ‫#رط‬.
•+‫ط‬ ‫ا‬ ‫و‬ ‫زا‬ ‫ا‬ ‫د@ت‬ ‫ا‬ ‫دة‬ ‫ز‬
•$ $ ‫ا‬ ‫رق‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ت‬ ‫ا‬
•‫ر‬ ‫=د‬3-5‫وات‬.
‫ر‬ ‫ظ‬‫ت‬ G/‫ور‬D ‫ا‬‫ا‬‫ك‬ ‫و‬ ‫ا‬،‫ن‬ ‫ل‬ =‫ا‬C
‫وات‬.
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
6
HORMONAL CHANGES
‫ا‬ ‫ض‬ ‫ر‬‫ء‬
‫ج‬ ‫إ‬ #
‫>ل‬ ‫ن‬ ‫رو‬ ‫ا‬
‫ن‬ ‫ر‬ ‫ر‬ A
‫ا‬ ‫م‬ ‫ا‬
substantial
amounts
‫د‬ ‫وات‬ ‫دة‬‫ن‬
‫ا‬.
•‫ا‬‫و‬‫ا‬‫$و‬tone‫ل‬ $‫$د‬ ‫ا‬ ،‫ظم‬ ‫وا‬ ،‫و‬.
•‫ص‬‫ت‬ ‫ا‬.
•‫>ون‬ ‫=د‬@‫ؤو‬ ‫أ‬‫/ن‬‫دة‬ ‫ز‬‫ن‬ ‫رط‬ّ‫ر‬ ‫ا‬ ‫ط‬‫م‬
‫6دي‬ ‫ا‬ ‫ن‬ ‫رط‬ ‫أو‬.
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
7
OVARIAN SENESCENCE
‫ا‬ ‫د‬،‫+رز‬ ‫و‬ C D ‫$و‬ ‫ا‬ G ‫ا‬‫رون‬ ‫رو‬ ‫ا‬‫رو‬ K # ‫إ‬‫ن‬.
‫ل‬ $ $ = ‫و‬ ‫ت‬ ‫ر‬ ‫ود‬ ‫و‬viable.
‫ج‬ ‫إ‬FSH‫و‬LH# ‫ض‬ ‫ر‬ # > ‫ت‬ >
‫وي‬ ‫ا‬ D.
CholesterolAndrostenedione and Testosterone)LH(
Estrogen.
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
8
‫وي‬ ‫ا‬ ‫ل‬ > ‫ا‬ ‫ل‬ ‫ل‬ 6‫دات‬ ‫رو‬ $.‫ل‬‫دات‬ ‫رو‬ ‫ا‬‫ا‬ ‫$ون‬ ‫ا‬ ‫ا‬‫$ون‬ ‫>ظر‬ ‫وا‬ ‫ر‬
‫زرق‬ ‫ا‬.
Cmpd B:‫رون‬ ‫>و‬ ‫>ور‬،Cmpd S:II->‫زو‬ ‫د‬‫زول‬ ‫>ور‬،DH:‫ز‬G >‫درو‬ ‫ھ‬،DHEA:‫رون‬ ‫درو‬ ‫دروإ‬ ‫د‬،
DOC:
>‫زو‬ ‫د‬‫رون‬ ‫>و‬ ‫>ور‬،LH:‫ون‬ ‫ر‬ ‫ا‬‫ن‬ ‫$و‬ ‫ا‬،P450c:‫و>روم‬ ‫ا‬P450.
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
‫ن‬ !‫"رو‬ 4‫ا‬
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
9
‫ا‬ ‫ن‬ ‫6د‬
‫م‬ $ ‫*ض‬ "E2‫م‬ $ >*"‫"ر‬ ‫$د‬E1
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
10
‫ت‬ !‫درو‬ 8‫ا‬
ANDROGENS
‫ا‬ ‫ن‬ ‫د‬ ‫ء‬ ‫ا‬‫ت‬ ‫درو‬ @‫ا‬ ‫ن‬ ‫أ=ل‬ ‫ت‬ > َ‫ن‬،َ‫$ن‬ O‫ن‬ ‫أ‬ @‫إ‬َ‫>ن‬ ‫ن‬
‫أ>6ر‬.
‫+رط‬ ‫ا‬ P ‫و‬ ‫ا‬ ‫ر‬ ‫و‬‫6دي‬ ‫ا‬ ‫م‬ ‫ص‬
‫ا‬ ‫ن‬ ‫د‬
‫دوران‬ ‫ا‬ # $ ‫ا‬ ‫ت‬ ‫درو‬ @‫ا‬ ‫وى‬ # ‫ض‬ + ‫ا‬ ‫د‬ ‫و‬.
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
‫"رون‬ !‫رو‬ ‫ا‬
PROGESTERONE
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
11
‫ص‬+ ‫ت‬ ‫و‬ % ‫إ‬ ‫رون‬ ‫رو‬ ‫ا‬ ‫ج‬ ‫إ‬.
‫ــ‬ # > ‫ر‬ A
•‫ول‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ت‬ ‫ز‬ ‫ا‬ ‫ض‬ ‫ر‬Estradiol% ‫إ‬Estrone sulfate
•‫$و‬ ‫ا‬ ‫ن‬ ‫رو‬ ‫ا‬ ‫ت‬G ‫ت‬ ‫و‬ ‫ص‬ ‫إ‬.
•‫دة‬ ‫ز‬ % ‫ا‬ ‫ؤدي‬ ‫=د‬ ، ‫ل‬ ‫وا‬ ‫ا‬ ‫ھذه‬(‫ا‬ٌ‫م‬ ِ ْ‫ا‬ِ "َ*mitosis‫ر‬ ‫ا‬ ‫ط‬ ‫ا‬ # ‫ن‬ ‫رو‬ ‫رض‬ ‫ا‬.
‫ر‬ ‫ا‬ ‫ط‬ ‫ا‬ # ‫#رازي‬ ‫ا‬ ‫ول‬ ‫ا‬ C ‫رون‬ ‫رو‬ ‫ا‬ ‫ب‬ A.
‫ـ‬ ً‫ة‬‫د‬ / ‫ا‬ ‫ن‬ ‫ول‬ ‫رة‬ # ‫را#ق‬ ، ‫ق‬:
•‫ظم‬ ‫ر‬ A $ ‫زف‬.
•‫$و‬ ‫وذ‬ @ C ‫م‬ ‫ر‬ ‫ا‬ ‫ط‬ C D ‫#رط‬.
•‫م‬ ‫ر‬ ‫ا‬ ‫ط‬ ‫ن‬ ‫رط‬ ‫دة‬ ‫ز‬.
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
‫د‬ ‫ا‬ ‫ت‬ ‫ا‬
GONADOTROPINS
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
12
‫ن‬ ‫رو‬ ‫ا‬GnRHLH‫و‬.FSH
‫أن‬ ‫د‬‫وا=ل‬ $D ‫ا‬‫$ـ‬CNS‫رات‬ 6;‫واز‬%$/‫ط‬
‫م‬ ‫ا‬ ‫رارة‬ ‫در‬ ‫م‬ ‫ظ‬‫ا‬P‫ن‬ ‫ر‬ ‫دة‬ ‫ز‬ ? + ‫ا‬
‫ا‬‫$د‬ ‫ا‬ # ‫رق‬ ‫وا‬ ّ‫م‬‫د‬–‫ا‬ ‫ت‬ ‫ا‬.
‫ـ‬ ‫وذ‬ ‫ا‬ ‫م‬ ‫ا‬FSH<20–40IU / L.
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
‫ر‬ ‫ر‬ ‫ا‬ ‫ھرات‬ ‫ظ‬ ‫ا‬
Clinical Manifestations
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
13
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
‫ت‬ ‫ا‬‫ا‬hot flashes.
‫رق‬ ‫ا‬Insomnia.
0 ‫ا‬Irritability.
‫زاج‬ ‫ا‬ ‫ت‬ ‫طرا‬ ‫ا‬Mood disturbances.
‫/راض‬ ‫ا‬)‫>رة‬ ‫ا‬(
$ ‫ا‬ ‫و‬ ‫ا‬ ‫ور‬ ‫ا‬.
‫دي‬ ‫ا‬ ‫ول‬ ‫ا‬ ‫$س‬.
‫$دي‬ ‫ا‬ ‫ن‬ @‫>و‬ ‫ا‬ ‫دان‬ #.
‫د‬ ‫ا‬ ‫د@ت‬ ‫ا‬)‫ط‬ ‫و‬ ‫ا‬(
‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬.
‫ر‬ ‫زھ‬ ‫ا‬ ‫وع‬ ‫ن‬ ‫رف‬ ‫ا‬Dementia of the Alzheimer's type
)‫وارد‬possible.(
/‫و‬ ‫ا‬ $ ‫ا‬ ‫راض‬ ‫ا‬)‫وا‬ ‫ر‬ A =G/.(
‫ون‬ ‫>و‬ ‫ا‬ ‫ن‬ ‫رط‬ ‫6ل‬ ‫ت‬ ‫رط‬ ‫ا‬)‫وا‬ ‫ر‬ A =G/.(
‫راض‬ ‫ا‬)‫رة‬ ; ‫ا‬(
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
14
‫ن‬ !‫"رو‬ (‫ا‬ ‫دان‬ C DE "
TABLE 35-1. CONSEQUENCE OF ESTROGEN LOSS
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
15
‫ا‬ ‫/راض‬ ‫ا‬
GENERAL SYMPTOMS
‫ا‬ ‫ت‬ ‫ا‬)85%‫ء‬ ‫ا‬ ‫ن‬. (
•‫ن‬ /‫ز‬ @ ‫ء‬ ‫ا‬ ‫ھؤ@ء‬ ‫ف‬D‫>ل‬‫ر‬ >.
•‫وا‬ ‫د‬ /40%‫ا‬ ‫ت‬ ‫ا‬ ‫#[ن‬ ، ‫ت‬ D ‫ا‬ ‫ء‬ ‫ا‬ ‫ن‬‫ھ‬‫ا‬‫ة‬‫>6ر‬ ‫ا‬ً /‫إز‬.
•‫دث‬A‫وا‬8-15‫و‬ ‫رة‬.
•‫ق‬ّ‫ر‬ ‫را#ق‬ ‫=د‬‫دوار‬ ‫ا‬ ،‫ن‬ + ‫وا‬ ،.
•‫رأة‬ ‫ا‬ ‫و=ظ‬ ‫=د‬‫ز‬‫ا‬ ‫دة‬‫و‬ ‫ء‬ /‫ل‬ + ‫ا‬.
•A ‫ء‬ ‫ا‬ %‫ط‬‫ت‬ > ‫ا‬‫ت‬ ّ‫و‬ ‫ا‬ ،+ ‫ا‬ ‫ا@دو‬ ‫أو‬ ،.
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
6 ‫ا‬ ‫ا8,راض‬
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
16
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
$ ‫ا‬ ‫و‬ ‫ا‬ ‫/راض‬ ‫ا‬
UROGENITAL SYMPTOMS
‫ن‬ ‫و‬ ‫ر‬ ‫ا‬ ‫ج‬G ‫ا‬
‫وري‬ ‫ا‬ ‫ل‬ ‫ا‬ ‫ب‬ ‫ا‬
‫وظ‬ $ ‫>ل‬@ P >
C ‫أن‬ C ‫ط‬‫>ل‬
# >‫$س‬ ‫ا‬ 0 ‫أو‬
‫و‬ ‫ا‬.
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
17
‫ب‬ A‫ن‬ ‫رو‬ ‫ا‬
C # ‫و‬ =‫ر‬ ‫رة‬ ‫ظ‬
‫=$وي‬ ‫إ#راز‬( pH > 7.0 ).
‫ق‬‫و‬ ‫ل‬ ‫ا‬ ‫=طر‬‫ق‬
‫و‬ ‫ق‬ّ‫ز‬ ‫و‬
‫وري‬ ‫ا‬ ‫ل‬ ‫ا‬ ‫ب‬ ‫ا‬:
0/‫ز‬ ‫ف‬ +.
‫ت‬.
‫دة‬ ‫د‬ ‫ع‬ ‫رة‬ /.
‫و‬ ‫ا‬ ‫/راض‬ ‫ا‬
‫دد‬‫ت‬G ‫ا‬.
‫و‬ ‫ا‬ ‫ر‬ ‫ز‬ ‫ا‬.
$ $ ‫ا‬ ‫وال‬ ‫ا‬
nocturia
‫ا‬‫و‬ ‫ا‬ ‫$س‬.
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬OSTEOPOROSIS
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
18
‫ن‬ ‫رو‬ ‫ا‬ ‫ن‬ ‫ن‬ ‫ر‬ ‫ا‬‫وز‬ ‫ظم‬ ‫ا‬ ‫رات‬ > ‫ط‬
‫م‬ ‫ظ‬ ‫ا‬ ‫ب‬ >‫ر‬ %$/ ‫ظم‬ ‫ا‬ ‫ت‬ ‫=درة‬lay down bon
‫م‬ ‫ظ‬ ‫ا‬ $=osteopenia‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬ ‫و‬osteoporosis
•‫طول‬ ‫ا‬ # ‫دان‬ #<1.5‫ش‬ ‫ا‬
•‫ورك‬ ‫ا‬ ‫و‬ ‫م‬D ‫ا‬ ‫ور‬ >:
•‫د‬10–15، ‫ا‬ ‫ن‬ %$/> ‫وز‬‫و‬‫ر‬‫ا‬‫م‬ ‫ظ‬‫د‬ /‫ا‬ ‫$ك‬ ‫ء‬ ‫ا‬/‫د‬
‫ل‬ ‫ر‬ ‫ا‬‫ـ‬3-5‫ف‬ ‫أ‬.
•‫و=ت‬ ‫ن‬ ‫د‬ ‫ظم‬ ‫ا‬ ‫ر=ق‬ ‫دث‬ $> ،‫>ر‬ ‫أ‬ ‫ء‬ ‫ا‬ ‫د‬ / ‫ن‬ ‫رو‬ ‫ا‬ ‫دان‬ # ‫ن‬ > $>‫>ر‬ ‫أ‬.
•‫ري‬ + ‫ا‬ ‫ود‬ ‫ا‬‫و‬‫ذ‬ + ‫ا‬ ‫ق‬ /‫ر‬ >$ ‫رض‬ ‫ا‬ ‫م‬ ‫ظ‬ ‫ا‬ ‫أ>6ر‬ ‫ھ‬.
‫ر‬ ‫ر‬ ‫ا‬ ‫ت‬ G ‫ا‬
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬OSTEOPOROSIS
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
19
‫طورة‬ ‫ا‬ ‫ل‬ ‫/وا‬‫طورة‬ ‫ا‬ ‫ل‬ ‫/وا‬
$ / D=
‫ل‬ ‫ا‬ ‫م‬ ‫ا‬
‫و‬ ‫ض‬ ‫ا‬‫وي‬ _‫ا‬ ‫رق‬ ‫ا‬
‫ا‬ ‫ط‬‫ة‬‫ا‬‫ر‬
‫ول‬‫ول‬ > ‫ا‬
‫ن‬ ‫د‬ ‫ا‬
‫درق‬ ‫ا‬ ‫ط‬ ‫#رط‬
‫إ‬‫دام‬‫أو‬ ‫دات‬ ‫رو‬ ‫ا‬‫ج‬G @‫ا‬ ‫دات‬
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
‫د‬ ‫د‬ ‫ا‬ ‫ظ‬ ‫ا‬ # 6> ‫ا‬ ‫س‬ = ‫دة‬ /‫إ‬ ‫ب‬6‫ج‬G ‫ا‬ ‫ن‬ ‫=ل‬ ‫ا‬ %$/ ‫ور‬
‫ا‬ ‫ن‬ ‫د‬ ‫ء‬ ‫ا‬ ‫د‬ / ‫دوا‬ ‫ا‬ ‫ج‬G %D‫و‬‫ر‬ CT_‫ا‬ ‫و#ق‬
)-2.0(–)-2.5(SD+‫ر‬ >$ # ‫إ‬ ‫طورة‬ ‫ل‬ / >-2.5SD
‫ر‬ > ‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬ ‫رف‬T>-2.5SD
‫ر‬ ‫ا‬T)(T score:‫ا‬‫ت‬ #‫را‬‫ا‬‫ر‬)SDs(‫ظ‬ ‫ا‬ ‫د‬ ‫ا‬ # 6> ‫ا‬ ‫/ن‬‫ط‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ت‬ c ‫ا‬ ‫د‬ / ‫وى‬D ‫ا‬‫ت‬
D‫و‬%‫ظ‬ ‫ا‬ ‫د‬ ‫ا‬ # 6> ‫ا‬ d‫ص‬‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬
‫ر‬≤65‫طورة‬ ‫ل‬ ‫/وا‬ ‫دون‬ ‫ء‬ ‫ا‬ # ‫ر‬≤50‫د‬ /‫ا‬ ‫ء‬ ‫ا‬‫$وا‬‫دھ‬ /‫ن‬‫طورة‬ ‫ل‬ ‫/وا‬.
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
20
‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬OSTEOPOROSIS
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
21
‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬OSTEOPOROSIS
‫ص‬ ‫إ‬‫طر‬‫ور‬ > ‫ا‬‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬ ‫/ن‬ ‫ا‬
•1200% ‫ا‬1500ً ‫و‬ ‫وم‬ > e$
•400% ‫ا‬600‫ن‬ # ‫دة‬ ‫و‬Dً ‫و‬
•‫و‬ ‫ا‬‫ر‬‫وزن‬ ‫ا‬ ‫ل‬
•‫ن‬ ‫ل‬G=@‫ا‬‫ول‬‫ول‬ > ‫ا‬
•‫ن‬ ‫د‬ ‫ا‬ ‫ف‬ ‫إ‬
•‫;>د‬ $ ‫درق‬ ‫ا‬ ‫ور‬D ‫ض‬ ‫ا‬ ‫و‬ ‫ر‬ ‫ا‬ ‫ج‬G ‫ا‬ ‫ون‬ $ ‫ن‬ ‫ذ‬ ‫ا‬ % ‫ر‬ ‫ا‬ ‫ص‬ # ‫ب‬‫/دم‬ ‫ن‬
‫دة‬ ‫زا‬ /‫ر‬ ‫م‬ $
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
22
•Estrogen)±Progestin(
•‫ن‬ ‫ر>ب‬ ‫ا‬ ‫ج‬G ‫ا‬Estrogen‫و‬Progestin‫ص‬‫ن‬ ‫د‬ ‫ور‬ > ‫ا‬ ‫إ‬
‫ـ‬ ‫ا‬ ‫دود‬ ‫;س‬ ‫ا‬24%C ،‫إ‬+‫ض‬34%‫ورك‬ ‫ا‬ ‫ور‬ > #
•‫د‬‫ا‬ ‫ن‬ ‫رو‬ @‫ا‬ ‫ل‬ ‫@ت‬SERMs)raloxifene(
•‫ور‬ > ‫ا‬ ‫ن‬ =‫و‬ ‫ا‬ # ‫دة‬ + ‫أ‬ ‫د‬ ‫و‬‫ر‬ + ‫ا‬
•bisphosphonates)alendronate(
•# #=‫و‬ ‫ا‬‫و‬ ،%$/‫أ‬ ‫ت‬ /‫ر‬# ،‫ج‬G/‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬
•$ $= ‫رات‬ 6;.
•‫>ل‬ ‫ذ‬ ‫ؤ‬ ‫أن‬ ‫ب‬& '.
•Calcitonin.
•‫درق‬ ‫ا‬ ‫رات‬ ‫ون‬ ‫ھر‬.
‫دوا‬ ‫ا‬ ‫ج‬G ‫ا‬
‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬OSTEOPOROSIS
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
‫ا‬ ‫و‬ ‫ر‬ ‫ا‬ ‫ج‬G ‫ا‬
OVARIAN HORMONE THERAPY
‫ت‬ ‫ط‬ @‫ا‬‫ا‬ ‫ت‬ ‫ا‬
" ‫ا‬ ‫و‬ ‫ا‬ ‫ور‬ ‫ا‬
‫م‬ ‫6ظ‬ ‫ا‬ ‫"ر$ق‬ ‫ن‬ $‫و‬ ‫ا‬
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
23
‫د‬ ‫+وا‬ ‫ا‬‫دا‬ ‫ر‬ ‫ؤ‬ ‫أو‬ ‫$د‬‫ا‬ ‫راض‬ ‫أ‬‫ب‬‫د‬ '6 ‫ا‬ ‫ر‬I ‫ا‬
arteriosclerotic‫ر‬ ‫زھ‬ ‫ا‬ ‫وداء‬
‫طر‬ ‫ا‬‫دي‬ ‫ور‬ ‫ا‬ ‫ر‬ ‫ا‬
‫و‬E‫ر‬ ‫ا‬ ' ‫ا‬
‫دي‬ ‫ا‬ ‫ن‬ ‫رط‬
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
6 ‫ا‬ ‫ا‬ ‫و‬ ‫ر‬ ‫ا‬ ! 6 ‫ا‬ ‫ر‬ ‫"د‬
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
24
‫ج‬N, +‫"6ط‬ (‫أ‬ ‫!ب‬ ً ‫ر‬ ‫0ن‬ " ‫ن‬ ‫"ز‬ ( "‫وا‬ ‫ا‬ ‫ء‬ ‫ا‬!‫"رو‬ ‫ا‬‫0س‬ 6 ‫ر‬ P.
‫م‬ ‫ر‬ ‫ا‬ ‫ط‬ ‫ن‬ ‫رط‬ ‫دوث‬ ‫ن‬ ‫ق‬C‫را‬ ‫ا‬ ‫ن‬ " !‫رو‬ ‫ا‬ ‫ء‬ ‫ا,ط‬.
‫ن‬ 6" ‫أن‬ ‫0ن‬ ‫ا‬ ‫ن‬ 0 ‫ا‬ ‫ث‬ ‫ط‬ ‫ا‬ ‫ع‬ ‫ط‬ ‫ن‬ P‫"ر‬ "‫وا‬ ‫ا‬ ‫ت‬ ‫ر‬ ‫ا‬‫ن‬ !‫"رو‬ 4‫ا‬‫وا‬‫ن‬ " !‫رو‬
‫ر‬ " ‫0ل‬I 0‫"ر‬I ‫ا‬.
•‫"0ون‬ ‫$د‬‫ت‬ " !‫رو‬ ‫ا‬‫دي‬ ‫ا‬ ‫ن‬ ‫رط‬ ‫دوث‬ ‫طر‬ ‫ا8ھم‬ ‫'ر‬ 6 ‫ا‬<<‫ء‬ ‫ا,ط‬ ‫!ب‬ R ‫أ‬ ‫د‬ "6‫ن‬ !‫"رو‬ 4‫ا‬‫ف‬ * "
‫"6رض‬ ‫ا‬ ‫ن‬‫ت‬ " !‫رو‬.
‫ن‬ ‫ر‬ 08 >‫ط‬ " ‫ا‬ ‫زف‬ ‫ا‬ ‫او‬ ‫ر‬ " ‫ا‬ ‫د‬ ‫د‬I ‫ا‬ ‫زف‬ ‫ا‬ ,‫"د‬4‫ر‬ C‫آ‬ ‫,ن‬ ‫ث‬ ‫ا‬ ‫و‬ ‫ر‬ ‫ا‬ ! 6 ‫ا‬ ‫ن‬ ‫ر‬ I‫أ‬.
‫دم‬ " " " ‫ا‬ ‫و‬ ‫ا‬ ‫ا8,راض‬ ‫ول‬ 8‫ا‬ ‫ر‬ ‫ا‬ ‫ھم‬ ‫"ر0ز‬ ‫ن‬‫ت‬ !‫"رو‬ 4‫ا‬C 6 ‫و‬ ‫ا‬‫ق‬ ‫"ط‬ ‫ل‬ ‫ا‬
‫ا‬ ‫ت‬ ‫0ر‬ ‫ا‬!‫"رو‬ 4‫ا‬،‫ب‬ ‫,دة‬ $ ‫ق‬C‫و‬ ‫دم‬ " " ‫أن‬ ‫0ن‬ " ‫ا‬ ‫ت‬ ‫ا‬ ‫أو‬ ‫ت‬ ‫وط‬U ‫ا‬-‫دو‬ ! ‫ا‬‫رورة‬ ‫ن‬
‫د‬ ‫أ‬ C ‫إ‬‫ت‬ " !‫رو‬ ‫ا‬.
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
‫ت‬N " ‫6د(ت‬‫ن‬ !‫"رو‬ 4‫ا‬E " (‫ا‬SERMS
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
25
•‫ط‬ ‫وا‬‫ت‬ ‫رو‬ ‫ا‬‫ط‬ ‫را‬ ‫ا‬ ‫د‬ ‫ل‬ ‫ا‬ ‫ل‬G ‫ن‬ ‫م‬ ‫ا‬ # ‫و‬ ‫ا‬ #‫أ‬-‫ا‬% ‫إ‬ ‫ل‬
+$ ‫ت‬ 6‫ور‬ ‫ط‬ 6 ‫أو‬ ‫ل‬ + ‫م‬ ‫ث‬ ‫واة‬ ‫ا‬‫ن‬ ‫رو‬ K.
•‫ت‬G ‫ن‬ ‫=ل‬ ‫ا‬ %$/ ‫ن‬ /‫و‬ ‫ود‬ ‫و‬ ‫رف‬‫ن‬ ‫رو‬ ‫ا‬،‫و‬ + ‫أ‬.
•‫ل‬ ‫ا‬ ‫+س‬ C ‫دات‬ ‫>ل‬ ‫ط‬ ‫ر‬ +$ ‫ط‬ ‫روا‬ ‫ك‬ ‫ھ‬،‫و‬ # ‫ط‬+$.
•‫دام‬ ‫ا‬ %SERMs%$/ ‫ول‬D $ ‫ق‬ ‫ا‬ ‫ھذه‬ ‫ن‬ ‫دة‬ + @‫ا‬ % ‫ا‬%$/‫رات‬ 6; ‫ا‬ ‫ض‬
‫و‬ ‫ا‬‫ول‬ ‫راد‬ K‫ط‬ ‫ا‬.
•SERMs‫ن‬ ‫د‬ ‫ا‬Clomiphene‫و‬Tamoxifen‫و‬Raloxifen.
•‫ن‬ + >‫و‬ ‫را‬Raloxifen:
•‫6ر‬ > ‫ا‬ ‫رض‬ @‫ري‬ ‫ظ‬ ‫ا‬‫6دي‬ ‫ا‬ =‫أ‬ ‫أو‬ ‫م‬ ‫ر‬ ‫ا‬ ‫ط‬ #.
•‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬ ‫ن‬ ‫و‬ ‫ظم‬ ‫ا‬ ‫رات‬ > # ‫ن‬ ‫+ف‬ ‫ن‬ + >‫و‬ ‫را‬ ‫ا‬ ‫أن‬ ‫دو‬.
•‫أن‬ ‫دو‬‫ن‬ + >‫و‬ ‫را‬ ‫ا‬‫ن‬ ً@‫د‬ /‫و‬ ‫ا‬ >‫ر‬ ‫ا‬ ‫/راض‬ ‫ا‬ % ‫ا‬ ‫ء‬.
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
‫ا‬ ‫ن‬ ‫د‬ ‫ا‬ ! 6 ‫ا‬ ‫و‬ ‫ة‬ ‫ا‬ ‫ط‬ ‫ل‬ ‫"6د‬
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
26
‫ة‬ ‫ا‬ ‫ط‬ ‫ت‬N ‫"6د‬
•‫ن‬ ‫ا‬ C ‫دم‬ " ‫ا‬ ‫رورة‬ " ‫ا‬ ‫رات‬ /" ‫ا‬ ‫ف‬ * " ‫طر‬.
•‫ھو‬ ‫ا8ھم‬ ‫ر‬ U" ‫ا‬‫ن‬ ‫"د‬ ‫ا‬ ‫ف‬ ‫إ‬.
•‫وزن‬ ‫ا‬ + , ‫طرة‬ ‫ا‬.
•‫"ظ‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ر‬.
•‫م‬ ‫د‬ ‫ا‬ ‫ن‬ ‫ل‬ $ ‫"وى‬ ‫ذات‬ ‫ر‬ 0‫أ‬ ' ‫"واز‬ E‫ذا‬P ‫ول‬ ".
•‫ص‬ ‫0ل‬I ‫و‬،‫أدو‬ ‫ر‬ "6"‫ت‬ " " ‫ا‬‫ا‬ ‫ن‬ ‫6د‬ ‫ء‬ ' ‫أھ‬ ‫ذات‬
‫دم‬ ‫ا‬ ‫وم‬ I C ‫طراب‬ ‫ا‬ ‫ن‬ ‫د‬ "‫وا‬ ‫ا‬.
‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬
‫ا‬ ‫ن‬ C ‫د‬ ‫ا‬ ! 6 ‫ا‬ ‫و‬ ‫ة‬ ‫ا‬ ‫ط‬ ‫ل‬ ‫"6د‬
02،‫ر‬ ‫أ‬19
DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY
FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY
27
‫ت‬ 0‫ر‬ ‫وق‬ "‫ن‬ !‫"رو‬ ‫"وإ‬ * ‫ا‬)Phytoestrogens(‫أ‬ + , ‫ن‬E ‫ز‬ " ‫واد‬ ‫و‬
‫د‬ " ‫ا‬ ‫و‬ ‫ر‬ ‫ا‬ ! 6 ً 6 ‫ط‬ ُN ‫د‬.
‫ء‬ ‫ا‬ + , ‫!ب‬‫ل‬ 0‫در‬ ‫"0ون‬ ‫أن‬:
‫وھ‬ ‫ا‬ ‫ج‬N6 ‫ا‬ +"placebo‫ا8,راض‬ ‫6ض‬ ‫*ف‬ ‫$د‬.
‫رة‬ +" ‫أو‬ ‫دة‬ * ‫ر‬ P I6 ‫ا‬ ‫رات‬ " ‫ا‬ ‫6ض‬ ‫أن‬ ‫ت‬ ‫إ‬ ‫"م‬.
‫ت‬ !" ‫ا‬ ‫ھذه‬ R ‫""6رض‬ ‫ذي‬ ‫ا‬ ‫'را‬ ‫ا8$ل‬ ‫م‬ ‫ظ‬ " ‫ا‬ ‫و‬ ‫م‬ " ‫ا‬.

More Related Content

More from Hisham Al-Hammami

4 female reproductive physiology
4 female reproductive physiology4 female reproductive physiology
4 female reproductive physiology
Hisham Al-Hammami
 
2 clinical approach to the patient dr hisham al hammami 2020
2 clinical approach to the patient dr hisham al hammami 20202 clinical approach to the patient dr hisham al hammami 2020
2 clinical approach to the patient dr hisham al hammami 2020
Hisham Al-Hammami
 
36 menstrual cycle influenced disorders dr hisham al-hammami powerpoint
36 menstrual cycle influenced disorders dr hisham al-hammami powerpoint36 menstrual cycle influenced disorders dr hisham al-hammami powerpoint
36 menstrual cycle influenced disorders dr hisham al-hammami powerpoint
Hisham Al-Hammami
 
32 amenorrhea, oligomenorrhea, and hyperandrogenic disorders dr.hisham al ham...
32 amenorrhea, oligomenorrhea, and hyperandrogenic disorders dr.hisham al ham...32 amenorrhea, oligomenorrhea, and hyperandrogenic disorders dr.hisham al ham...
32 amenorrhea, oligomenorrhea, and hyperandrogenic disorders dr.hisham al ham...
Hisham Al-Hammami
 
31 puberty and disorders of pubertal development dr.hisham al hammami 2020 po...
31 puberty and disorders of pubertal development dr.hisham al hammami 2020 po...31 puberty and disorders of pubertal development dr.hisham al hammami 2020 po...
31 puberty and disorders of pubertal development dr.hisham al hammami 2020 po...
Hisham Al-Hammami
 
27 family planning reversible contraception, sterilization, and abortion
27   family planning  reversible contraception, sterilization, and abortion27   family planning  reversible contraception, sterilization, and abortion
27 family planning reversible contraception, sterilization, and abortion
Hisham Al-Hammami
 
26 abnormal uterine bleeding powerpoint 2020
26    abnormal uterine bleeding powerpoint 202026    abnormal uterine bleeding powerpoint 2020
26 abnormal uterine bleeding powerpoint 2020
Hisham Al-Hammami
 
24 ectopic pregnancy -dr hisham al-hammami 2020 powerpoint
24    ectopic pregnancy -dr hisham al-hammami 2020 powerpoint24    ectopic pregnancy -dr hisham al-hammami 2020 powerpoint
24 ectopic pregnancy -dr hisham al-hammami 2020 powerpoint
Hisham Al-Hammami
 
22 vulvovaginitis, sexually transmitted infections, and pelvic inflammatory d...
22 vulvovaginitis, sexually transmitted infections, and pelvic inflammatory d...22 vulvovaginitis, sexually transmitted infections, and pelvic inflammatory d...
22 vulvovaginitis, sexually transmitted infections, and pelvic inflammatory d...
Hisham Al-Hammami
 
21 pelvic pain dr hisham al hammami 2020 powerpoint
21 pelvic pain dr hisham al hammami 2020 powerpoint21 pelvic pain dr hisham al hammami 2020 powerpoint
21 pelvic pain dr hisham al hammami 2020 powerpoint
Hisham Al-Hammami
 
20 congenital anomalies and benign conditions of the ovaries and fallopian tu...
20 congenital anomalies and benign conditions of the ovaries and fallopian tu...20 congenital anomalies and benign conditions of the ovaries and fallopian tu...
20 congenital anomalies and benign conditions of the ovaries and fallopian tu...
Hisham Al-Hammami
 
19 congenital anomalies and benign conditions of the uterine corpus and cervi...
19 congenital anomalies and benign conditions of the uterine corpus and cervi...19 congenital anomalies and benign conditions of the uterine corpus and cervi...
19 congenital anomalies and benign conditions of the uterine corpus and cervi...
Hisham Al-Hammami
 
18 congenital anomalies and benign conditions of the vulva and vagina dr hish...
18 congenital anomalies and benign conditions of the vulva and vagina dr hish...18 congenital anomalies and benign conditions of the vulva and vagina dr hish...
18 congenital anomalies and benign conditions of the vulva and vagina dr hish...
Hisham Al-Hammami
 
4 female reproductive physiology -dr hisham al-hammami 2020 powerpoint
4  female reproductive physiology -dr hisham al-hammami 2020 powerpoint4  female reproductive physiology -dr hisham al-hammami 2020 powerpoint
4 female reproductive physiology -dr hisham al-hammami 2020 powerpoint
Hisham Al-Hammami
 

More from Hisham Al-Hammami (14)

4 female reproductive physiology
4 female reproductive physiology4 female reproductive physiology
4 female reproductive physiology
 
2 clinical approach to the patient dr hisham al hammami 2020
2 clinical approach to the patient dr hisham al hammami 20202 clinical approach to the patient dr hisham al hammami 2020
2 clinical approach to the patient dr hisham al hammami 2020
 
36 menstrual cycle influenced disorders dr hisham al-hammami powerpoint
36 menstrual cycle influenced disorders dr hisham al-hammami powerpoint36 menstrual cycle influenced disorders dr hisham al-hammami powerpoint
36 menstrual cycle influenced disorders dr hisham al-hammami powerpoint
 
32 amenorrhea, oligomenorrhea, and hyperandrogenic disorders dr.hisham al ham...
32 amenorrhea, oligomenorrhea, and hyperandrogenic disorders dr.hisham al ham...32 amenorrhea, oligomenorrhea, and hyperandrogenic disorders dr.hisham al ham...
32 amenorrhea, oligomenorrhea, and hyperandrogenic disorders dr.hisham al ham...
 
31 puberty and disorders of pubertal development dr.hisham al hammami 2020 po...
31 puberty and disorders of pubertal development dr.hisham al hammami 2020 po...31 puberty and disorders of pubertal development dr.hisham al hammami 2020 po...
31 puberty and disorders of pubertal development dr.hisham al hammami 2020 po...
 
27 family planning reversible contraception, sterilization, and abortion
27   family planning  reversible contraception, sterilization, and abortion27   family planning  reversible contraception, sterilization, and abortion
27 family planning reversible contraception, sterilization, and abortion
 
26 abnormal uterine bleeding powerpoint 2020
26    abnormal uterine bleeding powerpoint 202026    abnormal uterine bleeding powerpoint 2020
26 abnormal uterine bleeding powerpoint 2020
 
24 ectopic pregnancy -dr hisham al-hammami 2020 powerpoint
24    ectopic pregnancy -dr hisham al-hammami 2020 powerpoint24    ectopic pregnancy -dr hisham al-hammami 2020 powerpoint
24 ectopic pregnancy -dr hisham al-hammami 2020 powerpoint
 
22 vulvovaginitis, sexually transmitted infections, and pelvic inflammatory d...
22 vulvovaginitis, sexually transmitted infections, and pelvic inflammatory d...22 vulvovaginitis, sexually transmitted infections, and pelvic inflammatory d...
22 vulvovaginitis, sexually transmitted infections, and pelvic inflammatory d...
 
21 pelvic pain dr hisham al hammami 2020 powerpoint
21 pelvic pain dr hisham al hammami 2020 powerpoint21 pelvic pain dr hisham al hammami 2020 powerpoint
21 pelvic pain dr hisham al hammami 2020 powerpoint
 
20 congenital anomalies and benign conditions of the ovaries and fallopian tu...
20 congenital anomalies and benign conditions of the ovaries and fallopian tu...20 congenital anomalies and benign conditions of the ovaries and fallopian tu...
20 congenital anomalies and benign conditions of the ovaries and fallopian tu...
 
19 congenital anomalies and benign conditions of the uterine corpus and cervi...
19 congenital anomalies and benign conditions of the uterine corpus and cervi...19 congenital anomalies and benign conditions of the uterine corpus and cervi...
19 congenital anomalies and benign conditions of the uterine corpus and cervi...
 
18 congenital anomalies and benign conditions of the vulva and vagina dr hish...
18 congenital anomalies and benign conditions of the vulva and vagina dr hish...18 congenital anomalies and benign conditions of the vulva and vagina dr hish...
18 congenital anomalies and benign conditions of the vulva and vagina dr hish...
 
4 female reproductive physiology -dr hisham al-hammami 2020 powerpoint
4  female reproductive physiology -dr hisham al-hammami 2020 powerpoint4  female reproductive physiology -dr hisham al-hammami 2020 powerpoint
4 female reproductive physiology -dr hisham al-hammami 2020 powerpoint
 

35 climacteric dr.hisham al hammami 2020 powerpoint

  • 1. 35-‫ا‬ ‫ن‬ 35 - CLIMACTERIC 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 1
  • 2. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ ‫ول‬ ‫و‬ ‫ا‬ ‫ن‬-‫ا‬ ‫ن‬ ‫د‬ ‫و‬ MENOPAUSE AND PERI- AND POSTMENOPAUSE 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 2
  • 3. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 3 ‫ر‬‫ا‬ ‫ن‬‫در‬ ‫ص‬ ‫دث‬ ‫ث‬ ‫ا‬ ‫رأة‬ ‫ا‬ ‫ة‬ # $ ‫ر‬ ‫ا‬ % ‫ا‬# ‫و‬ ‫ا‬ ‫دات‬ ‫رو‬ ‫ا‬ ‫ج‬ ‫إ‬ # ‫ص‬ % ‫ا‬ ‫ؤدي‬ ‫ا‬ + ‫وظ‬ ‫ا‬‫ك‬ ‫ذ‬ ‫/ن‬ 0. ‫ن‬ ‫دم‬ ‫ا‬ $ ‫ط‬ ‫ھو‬. ‫ا‬ ‫ن‬: 6 ‫ط‬ ‫دورة‬ ‫ر‬ ‫آ‬. ‫ث‬ ‫ط‬ ‫دون‬ ‫دة‬ ‫وا‬. 50-55.
  • 4. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 4 ‫ا‬ ‫د‬ ‫ا‬ ‫ت‬ ً !" ‫ا‬ ‫أ$ل‬ ‫ض‬ ‫ا‬ & '‫د‬ ! ‫د(ت‬ "،!‫و‬ ، *+" ‫و‬ !,‫ز‬ ‫رة‬+ , ‫ر‬ /" ‫0ون‬ ‫$د‬‫ط‬‫ة‬ ‫ا‬. ‫دث‬ "4‫ا‬4006 ‫رى‬ 8‫ا‬ ‫ت‬ ‫و‬ ‫ا‬ ‫0ل‬ ‫د‬ *"‫و‬ ، ‫رة‬‫ر"ق‬ ‫ا‬atresia. ‫وغ‬ ‫ا‬ ‫د‬ ,menarche:400,000 ‫و(دة‬ ‫ا‬ ‫د‬ ,:1.5‫ون‬oocytes.
  • 5. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 5 HORMONAL CHANGES ‫در‬‫أن‬‫;س‬ ‫ا‬ ‫ن‬ ‫دث‬‫و=ف‬ ‫>ل‬ %$/‫ا‬ + ‫وظ‬ ? +‫ض‬. •‫إ‬ @‫ظ‬ ‫ر‬ A 6 ‫ط‬ ‫دورات‬. •‫رة‬ ‫ز‬A ‫وث‬ ‫ط‬. •‫م‬ ‫ر‬ ‫ا‬ ‫ط‬ C D ‫#رط‬. •+‫ط‬ ‫ا‬ ‫و‬ ‫زا‬ ‫ا‬ ‫د@ت‬ ‫ا‬ ‫دة‬ ‫ز‬ •$ $ ‫ا‬ ‫رق‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ت‬ ‫ا‬ •‫ر‬ ‫=د‬3-5‫وات‬. ‫ر‬ ‫ظ‬‫ت‬ G/‫ور‬D ‫ا‬‫ا‬‫ك‬ ‫و‬ ‫ا‬،‫ن‬ ‫ل‬ =‫ا‬C ‫وات‬.
  • 6. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 6 HORMONAL CHANGES ‫ا‬ ‫ض‬ ‫ر‬‫ء‬ ‫ج‬ ‫إ‬ # ‫>ل‬ ‫ن‬ ‫رو‬ ‫ا‬ ‫ن‬ ‫ر‬ ‫ر‬ A ‫ا‬ ‫م‬ ‫ا‬ substantial amounts ‫د‬ ‫وات‬ ‫دة‬‫ن‬ ‫ا‬. •‫ا‬‫و‬‫ا‬‫$و‬tone‫ل‬ $‫$د‬ ‫ا‬ ،‫ظم‬ ‫وا‬ ،‫و‬. •‫ص‬‫ت‬ ‫ا‬. •‫>ون‬ ‫=د‬@‫ؤو‬ ‫أ‬‫/ن‬‫دة‬ ‫ز‬‫ن‬ ‫رط‬ّ‫ر‬ ‫ا‬ ‫ط‬‫م‬ ‫6دي‬ ‫ا‬ ‫ن‬ ‫رط‬ ‫أو‬.
  • 7. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 7 OVARIAN SENESCENCE ‫ا‬ ‫د‬،‫+رز‬ ‫و‬ C D ‫$و‬ ‫ا‬ G ‫ا‬‫رون‬ ‫رو‬ ‫ا‬‫رو‬ K # ‫إ‬‫ن‬. ‫ل‬ $ $ = ‫و‬ ‫ت‬ ‫ر‬ ‫ود‬ ‫و‬viable. ‫ج‬ ‫إ‬FSH‫و‬LH# ‫ض‬ ‫ر‬ # > ‫ت‬ > ‫وي‬ ‫ا‬ D. CholesterolAndrostenedione and Testosterone)LH( Estrogen.
  • 8. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 8 ‫وي‬ ‫ا‬ ‫ل‬ > ‫ا‬ ‫ل‬ ‫ل‬ 6‫دات‬ ‫رو‬ $.‫ل‬‫دات‬ ‫رو‬ ‫ا‬‫ا‬ ‫$ون‬ ‫ا‬ ‫ا‬‫$ون‬ ‫>ظر‬ ‫وا‬ ‫ر‬ ‫زرق‬ ‫ا‬. Cmpd B:‫رون‬ ‫>و‬ ‫>ور‬،Cmpd S:II->‫زو‬ ‫د‬‫زول‬ ‫>ور‬،DH:‫ز‬G >‫درو‬ ‫ھ‬،DHEA:‫رون‬ ‫درو‬ ‫دروإ‬ ‫د‬، DOC: >‫زو‬ ‫د‬‫رون‬ ‫>و‬ ‫>ور‬،LH:‫ون‬ ‫ر‬ ‫ا‬‫ن‬ ‫$و‬ ‫ا‬،P450c:‫و>روم‬ ‫ا‬P450.
  • 9. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ ‫ن‬ !‫"رو‬ 4‫ا‬ 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 9 ‫ا‬ ‫ن‬ ‫6د‬ ‫م‬ $ ‫*ض‬ "E2‫م‬ $ >*"‫"ر‬ ‫$د‬E1
  • 10. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 10 ‫ت‬ !‫درو‬ 8‫ا‬ ANDROGENS ‫ا‬ ‫ن‬ ‫د‬ ‫ء‬ ‫ا‬‫ت‬ ‫درو‬ @‫ا‬ ‫ن‬ ‫أ=ل‬ ‫ت‬ > َ‫ن‬،َ‫$ن‬ O‫ن‬ ‫أ‬ @‫إ‬َ‫>ن‬ ‫ن‬ ‫أ>6ر‬. ‫+رط‬ ‫ا‬ P ‫و‬ ‫ا‬ ‫ر‬ ‫و‬‫6دي‬ ‫ا‬ ‫م‬ ‫ص‬ ‫ا‬ ‫ن‬ ‫د‬ ‫دوران‬ ‫ا‬ # $ ‫ا‬ ‫ت‬ ‫درو‬ @‫ا‬ ‫وى‬ # ‫ض‬ + ‫ا‬ ‫د‬ ‫و‬.
  • 11. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ ‫"رون‬ !‫رو‬ ‫ا‬ PROGESTERONE 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 11 ‫ص‬+ ‫ت‬ ‫و‬ % ‫إ‬ ‫رون‬ ‫رو‬ ‫ا‬ ‫ج‬ ‫إ‬. ‫ــ‬ # > ‫ر‬ A •‫ول‬ ‫ا‬ ‫و‬ ‫ا‬ ‫ت‬ ‫ز‬ ‫ا‬ ‫ض‬ ‫ر‬Estradiol% ‫إ‬Estrone sulfate •‫$و‬ ‫ا‬ ‫ن‬ ‫رو‬ ‫ا‬ ‫ت‬G ‫ت‬ ‫و‬ ‫ص‬ ‫إ‬. •‫دة‬ ‫ز‬ % ‫ا‬ ‫ؤدي‬ ‫=د‬ ، ‫ل‬ ‫وا‬ ‫ا‬ ‫ھذه‬(‫ا‬ٌ‫م‬ ِ ْ‫ا‬ِ "َ*mitosis‫ر‬ ‫ا‬ ‫ط‬ ‫ا‬ # ‫ن‬ ‫رو‬ ‫رض‬ ‫ا‬. ‫ر‬ ‫ا‬ ‫ط‬ ‫ا‬ # ‫#رازي‬ ‫ا‬ ‫ول‬ ‫ا‬ C ‫رون‬ ‫رو‬ ‫ا‬ ‫ب‬ A. ‫ـ‬ ً‫ة‬‫د‬ / ‫ا‬ ‫ن‬ ‫ول‬ ‫رة‬ # ‫را#ق‬ ، ‫ق‬: •‫ظم‬ ‫ر‬ A $ ‫زف‬. •‫$و‬ ‫وذ‬ @ C ‫م‬ ‫ر‬ ‫ا‬ ‫ط‬ C D ‫#رط‬. •‫م‬ ‫ر‬ ‫ا‬ ‫ط‬ ‫ن‬ ‫رط‬ ‫دة‬ ‫ز‬.
  • 12. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ ‫د‬ ‫ا‬ ‫ت‬ ‫ا‬ GONADOTROPINS 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 12 ‫ن‬ ‫رو‬ ‫ا‬GnRHLH‫و‬.FSH ‫أن‬ ‫د‬‫وا=ل‬ $D ‫ا‬‫$ـ‬CNS‫رات‬ 6;‫واز‬%$/‫ط‬ ‫م‬ ‫ا‬ ‫رارة‬ ‫در‬ ‫م‬ ‫ظ‬‫ا‬P‫ن‬ ‫ر‬ ‫دة‬ ‫ز‬ ? + ‫ا‬ ‫ا‬‫$د‬ ‫ا‬ # ‫رق‬ ‫وا‬ ّ‫م‬‫د‬–‫ا‬ ‫ت‬ ‫ا‬. ‫ـ‬ ‫وذ‬ ‫ا‬ ‫م‬ ‫ا‬FSH<20–40IU / L.
  • 13. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ ‫ر‬ ‫ر‬ ‫ا‬ ‫ھرات‬ ‫ظ‬ ‫ا‬ Clinical Manifestations 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 13
  • 14. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ ‫ت‬ ‫ا‬‫ا‬hot flashes. ‫رق‬ ‫ا‬Insomnia. 0 ‫ا‬Irritability. ‫زاج‬ ‫ا‬ ‫ت‬ ‫طرا‬ ‫ا‬Mood disturbances. ‫/راض‬ ‫ا‬)‫>رة‬ ‫ا‬( $ ‫ا‬ ‫و‬ ‫ا‬ ‫ور‬ ‫ا‬. ‫دي‬ ‫ا‬ ‫ول‬ ‫ا‬ ‫$س‬. ‫$دي‬ ‫ا‬ ‫ن‬ @‫>و‬ ‫ا‬ ‫دان‬ #. ‫د‬ ‫ا‬ ‫د@ت‬ ‫ا‬)‫ط‬ ‫و‬ ‫ا‬( ‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬. ‫ر‬ ‫زھ‬ ‫ا‬ ‫وع‬ ‫ن‬ ‫رف‬ ‫ا‬Dementia of the Alzheimer's type )‫وارد‬possible.( /‫و‬ ‫ا‬ $ ‫ا‬ ‫راض‬ ‫ا‬)‫وا‬ ‫ر‬ A =G/.( ‫ون‬ ‫>و‬ ‫ا‬ ‫ن‬ ‫رط‬ ‫6ل‬ ‫ت‬ ‫رط‬ ‫ا‬)‫وا‬ ‫ر‬ A =G/.( ‫راض‬ ‫ا‬)‫رة‬ ; ‫ا‬( 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 14 ‫ن‬ !‫"رو‬ (‫ا‬ ‫دان‬ C DE " TABLE 35-1. CONSEQUENCE OF ESTROGEN LOSS
  • 15. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 15 ‫ا‬ ‫/راض‬ ‫ا‬ GENERAL SYMPTOMS ‫ا‬ ‫ت‬ ‫ا‬)85%‫ء‬ ‫ا‬ ‫ن‬. ( •‫ن‬ /‫ز‬ @ ‫ء‬ ‫ا‬ ‫ھؤ@ء‬ ‫ف‬D‫>ل‬‫ر‬ >. •‫وا‬ ‫د‬ /40%‫ا‬ ‫ت‬ ‫ا‬ ‫#[ن‬ ، ‫ت‬ D ‫ا‬ ‫ء‬ ‫ا‬ ‫ن‬‫ھ‬‫ا‬‫ة‬‫>6ر‬ ‫ا‬ً /‫إز‬. •‫دث‬A‫وا‬8-15‫و‬ ‫رة‬. •‫ق‬ّ‫ر‬ ‫را#ق‬ ‫=د‬‫دوار‬ ‫ا‬ ،‫ن‬ + ‫وا‬ ،. •‫رأة‬ ‫ا‬ ‫و=ظ‬ ‫=د‬‫ز‬‫ا‬ ‫دة‬‫و‬ ‫ء‬ /‫ل‬ + ‫ا‬. •A ‫ء‬ ‫ا‬ %‫ط‬‫ت‬ > ‫ا‬‫ت‬ ّ‫و‬ ‫ا‬ ،+ ‫ا‬ ‫ا@دو‬ ‫أو‬ ،.
  • 16. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ 6 ‫ا‬ ‫ا8,راض‬ 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 16
  • 17. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ $ ‫ا‬ ‫و‬ ‫ا‬ ‫/راض‬ ‫ا‬ UROGENITAL SYMPTOMS ‫ن‬ ‫و‬ ‫ر‬ ‫ا‬ ‫ج‬G ‫ا‬ ‫وري‬ ‫ا‬ ‫ل‬ ‫ا‬ ‫ب‬ ‫ا‬ ‫وظ‬ $ ‫>ل‬@ P > C ‫أن‬ C ‫ط‬‫>ل‬ # >‫$س‬ ‫ا‬ 0 ‫أو‬ ‫و‬ ‫ا‬. 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 17 ‫ب‬ A‫ن‬ ‫رو‬ ‫ا‬ C # ‫و‬ =‫ر‬ ‫رة‬ ‫ظ‬ ‫=$وي‬ ‫إ#راز‬( pH > 7.0 ). ‫ق‬‫و‬ ‫ل‬ ‫ا‬ ‫=طر‬‫ق‬ ‫و‬ ‫ق‬ّ‫ز‬ ‫و‬ ‫وري‬ ‫ا‬ ‫ل‬ ‫ا‬ ‫ب‬ ‫ا‬: 0/‫ز‬ ‫ف‬ +. ‫ت‬. ‫دة‬ ‫د‬ ‫ع‬ ‫رة‬ /. ‫و‬ ‫ا‬ ‫/راض‬ ‫ا‬ ‫دد‬‫ت‬G ‫ا‬. ‫و‬ ‫ا‬ ‫ر‬ ‫ز‬ ‫ا‬. $ $ ‫ا‬ ‫وال‬ ‫ا‬ nocturia ‫ا‬‫و‬ ‫ا‬ ‫$س‬.
  • 18. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬OSTEOPOROSIS 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 18 ‫ن‬ ‫رو‬ ‫ا‬ ‫ن‬ ‫ن‬ ‫ر‬ ‫ا‬‫وز‬ ‫ظم‬ ‫ا‬ ‫رات‬ > ‫ط‬ ‫م‬ ‫ظ‬ ‫ا‬ ‫ب‬ >‫ر‬ %$/ ‫ظم‬ ‫ا‬ ‫ت‬ ‫=درة‬lay down bon ‫م‬ ‫ظ‬ ‫ا‬ $=osteopenia‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬ ‫و‬osteoporosis •‫طول‬ ‫ا‬ # ‫دان‬ #<1.5‫ش‬ ‫ا‬ •‫ورك‬ ‫ا‬ ‫و‬ ‫م‬D ‫ا‬ ‫ور‬ >: •‫د‬10–15، ‫ا‬ ‫ن‬ %$/> ‫وز‬‫و‬‫ر‬‫ا‬‫م‬ ‫ظ‬‫د‬ /‫ا‬ ‫$ك‬ ‫ء‬ ‫ا‬/‫د‬ ‫ل‬ ‫ر‬ ‫ا‬‫ـ‬3-5‫ف‬ ‫أ‬. •‫و=ت‬ ‫ن‬ ‫د‬ ‫ظم‬ ‫ا‬ ‫ر=ق‬ ‫دث‬ $> ،‫>ر‬ ‫أ‬ ‫ء‬ ‫ا‬ ‫د‬ / ‫ن‬ ‫رو‬ ‫ا‬ ‫دان‬ # ‫ن‬ > $>‫>ر‬ ‫أ‬. •‫ري‬ + ‫ا‬ ‫ود‬ ‫ا‬‫و‬‫ذ‬ + ‫ا‬ ‫ق‬ /‫ر‬ >$ ‫رض‬ ‫ا‬ ‫م‬ ‫ظ‬ ‫ا‬ ‫أ>6ر‬ ‫ھ‬. ‫ر‬ ‫ر‬ ‫ا‬ ‫ت‬ G ‫ا‬
  • 19. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ ‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬OSTEOPOROSIS 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 19 ‫طورة‬ ‫ا‬ ‫ل‬ ‫/وا‬‫طورة‬ ‫ا‬ ‫ل‬ ‫/وا‬ $ / D= ‫ل‬ ‫ا‬ ‫م‬ ‫ا‬ ‫و‬ ‫ض‬ ‫ا‬‫وي‬ _‫ا‬ ‫رق‬ ‫ا‬ ‫ا‬ ‫ط‬‫ة‬‫ا‬‫ر‬ ‫ول‬‫ول‬ > ‫ا‬ ‫ن‬ ‫د‬ ‫ا‬ ‫درق‬ ‫ا‬ ‫ط‬ ‫#رط‬ ‫إ‬‫دام‬‫أو‬ ‫دات‬ ‫رو‬ ‫ا‬‫ج‬G @‫ا‬ ‫دات‬
  • 20. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ ‫د‬ ‫د‬ ‫ا‬ ‫ظ‬ ‫ا‬ # 6> ‫ا‬ ‫س‬ = ‫دة‬ /‫إ‬ ‫ب‬6‫ج‬G ‫ا‬ ‫ن‬ ‫=ل‬ ‫ا‬ %$/ ‫ور‬ ‫ا‬ ‫ن‬ ‫د‬ ‫ء‬ ‫ا‬ ‫د‬ / ‫دوا‬ ‫ا‬ ‫ج‬G %D‫و‬‫ر‬ CT_‫ا‬ ‫و#ق‬ )-2.0(–)-2.5(SD+‫ر‬ >$ # ‫إ‬ ‫طورة‬ ‫ل‬ / >-2.5SD ‫ر‬ > ‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬ ‫رف‬T>-2.5SD ‫ر‬ ‫ا‬T)(T score:‫ا‬‫ت‬ #‫را‬‫ا‬‫ر‬)SDs(‫ظ‬ ‫ا‬ ‫د‬ ‫ا‬ # 6> ‫ا‬ ‫/ن‬‫ط‬ ‫ا‬ ‫ت‬ ‫ا‬ ‫ت‬ c ‫ا‬ ‫د‬ / ‫وى‬D ‫ا‬‫ت‬ D‫و‬%‫ظ‬ ‫ا‬ ‫د‬ ‫ا‬ # 6> ‫ا‬ d‫ص‬‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬ ‫ر‬≤65‫طورة‬ ‫ل‬ ‫/وا‬ ‫دون‬ ‫ء‬ ‫ا‬ # ‫ر‬≤50‫د‬ /‫ا‬ ‫ء‬ ‫ا‬‫$وا‬‫دھ‬ /‫ن‬‫طورة‬ ‫ل‬ ‫/وا‬. 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 20 ‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬OSTEOPOROSIS
  • 21. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 21 ‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬OSTEOPOROSIS ‫ص‬ ‫إ‬‫طر‬‫ور‬ > ‫ا‬‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬ ‫/ن‬ ‫ا‬ •1200% ‫ا‬1500ً ‫و‬ ‫وم‬ > e$ •400% ‫ا‬600‫ن‬ # ‫دة‬ ‫و‬Dً ‫و‬ •‫و‬ ‫ا‬‫ر‬‫وزن‬ ‫ا‬ ‫ل‬ •‫ن‬ ‫ل‬G=@‫ا‬‫ول‬‫ول‬ > ‫ا‬ •‫ن‬ ‫د‬ ‫ا‬ ‫ف‬ ‫إ‬ •‫;>د‬ $ ‫درق‬ ‫ا‬ ‫ور‬D ‫ض‬ ‫ا‬ ‫و‬ ‫ر‬ ‫ا‬ ‫ج‬G ‫ا‬ ‫ون‬ $ ‫ن‬ ‫ذ‬ ‫ا‬ % ‫ر‬ ‫ا‬ ‫ص‬ # ‫ب‬‫/دم‬ ‫ن‬ ‫دة‬ ‫زا‬ /‫ر‬ ‫م‬ $
  • 22. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 22 •Estrogen)±Progestin( •‫ن‬ ‫ر>ب‬ ‫ا‬ ‫ج‬G ‫ا‬Estrogen‫و‬Progestin‫ص‬‫ن‬ ‫د‬ ‫ور‬ > ‫ا‬ ‫إ‬ ‫ـ‬ ‫ا‬ ‫دود‬ ‫;س‬ ‫ا‬24%C ،‫إ‬+‫ض‬34%‫ورك‬ ‫ا‬ ‫ور‬ > # •‫د‬‫ا‬ ‫ن‬ ‫رو‬ @‫ا‬ ‫ل‬ ‫@ت‬SERMs)raloxifene( •‫ور‬ > ‫ا‬ ‫ن‬ =‫و‬ ‫ا‬ # ‫دة‬ + ‫أ‬ ‫د‬ ‫و‬‫ر‬ + ‫ا‬ •bisphosphonates)alendronate( •# #=‫و‬ ‫ا‬‫و‬ ،%$/‫أ‬ ‫ت‬ /‫ر‬# ،‫ج‬G/‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬ •$ $= ‫رات‬ 6;. •‫>ل‬ ‫ذ‬ ‫ؤ‬ ‫أن‬ ‫ب‬& '. •Calcitonin. •‫درق‬ ‫ا‬ ‫رات‬ ‫ون‬ ‫ھر‬. ‫دوا‬ ‫ا‬ ‫ج‬G ‫ا‬ ‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬OSTEOPOROSIS
  • 23. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ ‫ا‬ ‫و‬ ‫ر‬ ‫ا‬ ‫ج‬G ‫ا‬ OVARIAN HORMONE THERAPY ‫ت‬ ‫ط‬ @‫ا‬‫ا‬ ‫ت‬ ‫ا‬ " ‫ا‬ ‫و‬ ‫ا‬ ‫ور‬ ‫ا‬ ‫م‬ ‫6ظ‬ ‫ا‬ ‫"ر$ق‬ ‫ن‬ $‫و‬ ‫ا‬ 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 23 ‫د‬ ‫+وا‬ ‫ا‬‫دا‬ ‫ر‬ ‫ؤ‬ ‫أو‬ ‫$د‬‫ا‬ ‫راض‬ ‫أ‬‫ب‬‫د‬ '6 ‫ا‬ ‫ر‬I ‫ا‬ arteriosclerotic‫ر‬ ‫زھ‬ ‫ا‬ ‫وداء‬ ‫طر‬ ‫ا‬‫دي‬ ‫ور‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫و‬E‫ر‬ ‫ا‬ ' ‫ا‬ ‫دي‬ ‫ا‬ ‫ن‬ ‫رط‬
  • 24. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ 6 ‫ا‬ ‫ا‬ ‫و‬ ‫ر‬ ‫ا‬ ! 6 ‫ا‬ ‫ر‬ ‫"د‬ 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 24 ‫ج‬N, +‫"6ط‬ (‫أ‬ ‫!ب‬ ً ‫ر‬ ‫0ن‬ " ‫ن‬ ‫"ز‬ ( "‫وا‬ ‫ا‬ ‫ء‬ ‫ا‬!‫"رو‬ ‫ا‬‫0س‬ 6 ‫ر‬ P. ‫م‬ ‫ر‬ ‫ا‬ ‫ط‬ ‫ن‬ ‫رط‬ ‫دوث‬ ‫ن‬ ‫ق‬C‫را‬ ‫ا‬ ‫ن‬ " !‫رو‬ ‫ا‬ ‫ء‬ ‫ا,ط‬. ‫ن‬ 6" ‫أن‬ ‫0ن‬ ‫ا‬ ‫ن‬ 0 ‫ا‬ ‫ث‬ ‫ط‬ ‫ا‬ ‫ع‬ ‫ط‬ ‫ن‬ P‫"ر‬ "‫وا‬ ‫ا‬ ‫ت‬ ‫ر‬ ‫ا‬‫ن‬ !‫"رو‬ 4‫ا‬‫وا‬‫ن‬ " !‫رو‬ ‫ر‬ " ‫0ل‬I 0‫"ر‬I ‫ا‬. •‫"0ون‬ ‫$د‬‫ت‬ " !‫رو‬ ‫ا‬‫دي‬ ‫ا‬ ‫ن‬ ‫رط‬ ‫دوث‬ ‫طر‬ ‫ا8ھم‬ ‫'ر‬ 6 ‫ا‬<<‫ء‬ ‫ا,ط‬ ‫!ب‬ R ‫أ‬ ‫د‬ "6‫ن‬ !‫"رو‬ 4‫ا‬‫ف‬ * " ‫"6رض‬ ‫ا‬ ‫ن‬‫ت‬ " !‫رو‬. ‫ن‬ ‫ر‬ 08 >‫ط‬ " ‫ا‬ ‫زف‬ ‫ا‬ ‫او‬ ‫ر‬ " ‫ا‬ ‫د‬ ‫د‬I ‫ا‬ ‫زف‬ ‫ا‬ ,‫"د‬4‫ر‬ C‫آ‬ ‫,ن‬ ‫ث‬ ‫ا‬ ‫و‬ ‫ر‬ ‫ا‬ ! 6 ‫ا‬ ‫ن‬ ‫ر‬ I‫أ‬. ‫دم‬ " " " ‫ا‬ ‫و‬ ‫ا‬ ‫ا8,راض‬ ‫ول‬ 8‫ا‬ ‫ر‬ ‫ا‬ ‫ھم‬ ‫"ر0ز‬ ‫ن‬‫ت‬ !‫"رو‬ 4‫ا‬C 6 ‫و‬ ‫ا‬‫ق‬ ‫"ط‬ ‫ل‬ ‫ا‬ ‫ا‬ ‫ت‬ ‫0ر‬ ‫ا‬!‫"رو‬ 4‫ا‬،‫ب‬ ‫,دة‬ $ ‫ق‬C‫و‬ ‫دم‬ " " ‫أن‬ ‫0ن‬ " ‫ا‬ ‫ت‬ ‫ا‬ ‫أو‬ ‫ت‬ ‫وط‬U ‫ا‬-‫دو‬ ! ‫ا‬‫رورة‬ ‫ن‬ ‫د‬ ‫أ‬ C ‫إ‬‫ت‬ " !‫رو‬ ‫ا‬.
  • 25. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ ‫ت‬N " ‫6د(ت‬‫ن‬ !‫"رو‬ 4‫ا‬E " (‫ا‬SERMS 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 25 •‫ط‬ ‫وا‬‫ت‬ ‫رو‬ ‫ا‬‫ط‬ ‫را‬ ‫ا‬ ‫د‬ ‫ل‬ ‫ا‬ ‫ل‬G ‫ن‬ ‫م‬ ‫ا‬ # ‫و‬ ‫ا‬ #‫أ‬-‫ا‬% ‫إ‬ ‫ل‬ +$ ‫ت‬ 6‫ور‬ ‫ط‬ 6 ‫أو‬ ‫ل‬ + ‫م‬ ‫ث‬ ‫واة‬ ‫ا‬‫ن‬ ‫رو‬ K. •‫ت‬G ‫ن‬ ‫=ل‬ ‫ا‬ %$/ ‫ن‬ /‫و‬ ‫ود‬ ‫و‬ ‫رف‬‫ن‬ ‫رو‬ ‫ا‬،‫و‬ + ‫أ‬. •‫ل‬ ‫ا‬ ‫+س‬ C ‫دات‬ ‫>ل‬ ‫ط‬ ‫ر‬ +$ ‫ط‬ ‫روا‬ ‫ك‬ ‫ھ‬،‫و‬ # ‫ط‬+$. •‫دام‬ ‫ا‬ %SERMs%$/ ‫ول‬D $ ‫ق‬ ‫ا‬ ‫ھذه‬ ‫ن‬ ‫دة‬ + @‫ا‬ % ‫ا‬%$/‫رات‬ 6; ‫ا‬ ‫ض‬ ‫و‬ ‫ا‬‫ول‬ ‫راد‬ K‫ط‬ ‫ا‬. •SERMs‫ن‬ ‫د‬ ‫ا‬Clomiphene‫و‬Tamoxifen‫و‬Raloxifen. •‫ن‬ + >‫و‬ ‫را‬Raloxifen: •‫6ر‬ > ‫ا‬ ‫رض‬ @‫ري‬ ‫ظ‬ ‫ا‬‫6دي‬ ‫ا‬ =‫أ‬ ‫أو‬ ‫م‬ ‫ر‬ ‫ا‬ ‫ط‬ #. •‫م‬ ‫ظ‬ ‫ا‬ ‫ر=ق‬ ‫ن‬ ‫و‬ ‫ظم‬ ‫ا‬ ‫رات‬ > # ‫ن‬ ‫+ف‬ ‫ن‬ + >‫و‬ ‫را‬ ‫ا‬ ‫أن‬ ‫دو‬. •‫أن‬ ‫دو‬‫ن‬ + >‫و‬ ‫را‬ ‫ا‬‫ن‬ ً@‫د‬ /‫و‬ ‫ا‬ >‫ر‬ ‫ا‬ ‫/راض‬ ‫ا‬ % ‫ا‬ ‫ء‬.
  • 26. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ ‫ا‬ ‫ن‬ ‫د‬ ‫ا‬ ! 6 ‫ا‬ ‫و‬ ‫ة‬ ‫ا‬ ‫ط‬ ‫ل‬ ‫"6د‬ 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 26 ‫ة‬ ‫ا‬ ‫ط‬ ‫ت‬N ‫"6د‬ •‫ن‬ ‫ا‬ C ‫دم‬ " ‫ا‬ ‫رورة‬ " ‫ا‬ ‫رات‬ /" ‫ا‬ ‫ف‬ * " ‫طر‬. •‫ھو‬ ‫ا8ھم‬ ‫ر‬ U" ‫ا‬‫ن‬ ‫"د‬ ‫ا‬ ‫ف‬ ‫إ‬. •‫وزن‬ ‫ا‬ + , ‫طرة‬ ‫ا‬. •‫"ظ‬ ‫ا‬ ‫ر‬ ‫ا‬ ‫ر‬. •‫م‬ ‫د‬ ‫ا‬ ‫ن‬ ‫ل‬ $ ‫"وى‬ ‫ذات‬ ‫ر‬ 0‫أ‬ ' ‫"واز‬ E‫ذا‬P ‫ول‬ ". •‫ص‬ ‫0ل‬I ‫و‬،‫أدو‬ ‫ر‬ "6"‫ت‬ " " ‫ا‬‫ا‬ ‫ن‬ ‫6د‬ ‫ء‬ ' ‫أھ‬ ‫ذات‬ ‫دم‬ ‫ا‬ ‫وم‬ I C ‫طراب‬ ‫ا‬ ‫ن‬ ‫د‬ "‫وا‬ ‫ا‬.
  • 27. ‫ا‬ ‫راض‬ ‫ا‬–‫ا‬ ‫ا‬ ‫ا‬ ‫ن‬ C ‫د‬ ‫ا‬ ! 6 ‫ا‬ ‫و‬ ‫ة‬ ‫ا‬ ‫ط‬ ‫ل‬ ‫"6د‬ 02،‫ر‬ ‫أ‬19 DR.HISHAM AL-HAMMAMI PROFESSOR OF OBSTETRICS AND GYNECOLOGY FACULTY OF MEDICINE SYRIAN PRIVATE UNIVERSITY 27 ‫ت‬ 0‫ر‬ ‫وق‬ "‫ن‬ !‫"رو‬ ‫"وإ‬ * ‫ا‬)Phytoestrogens(‫أ‬ + , ‫ن‬E ‫ز‬ " ‫واد‬ ‫و‬ ‫د‬ " ‫ا‬ ‫و‬ ‫ر‬ ‫ا‬ ! 6 ً 6 ‫ط‬ ُN ‫د‬. ‫ء‬ ‫ا‬ + , ‫!ب‬‫ل‬ 0‫در‬ ‫"0ون‬ ‫أن‬: ‫وھ‬ ‫ا‬ ‫ج‬N6 ‫ا‬ +"placebo‫ا8,راض‬ ‫6ض‬ ‫*ف‬ ‫$د‬. ‫رة‬ +" ‫أو‬ ‫دة‬ * ‫ر‬ P I6 ‫ا‬ ‫رات‬ " ‫ا‬ ‫6ض‬ ‫أن‬ ‫ت‬ ‫إ‬ ‫"م‬. ‫ت‬ !" ‫ا‬ ‫ھذه‬ R ‫""6رض‬ ‫ذي‬ ‫ا‬ ‫'را‬ ‫ا8$ل‬ ‫م‬ ‫ظ‬ " ‫ا‬ ‫و‬ ‫م‬ " ‫ا‬.